Seattle Cannabis Blockbuster Set to Double Sales in Next 2 Years!
Thanks to a recent reorganization, acquisitions, and strategic partnerships, one Seattle cannabis blockbuster is poised for a massive expansion in the coming 24 months. With plans to double its annual sales in the next two years, this company’s shares could potentially skyrocket in value.

NYSE:MTH - Meritage Homes Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $116.25
  • Forecasted Upside: 6.57 %
  • Number of Analysts: 10
  • Breakdown:
  • 0 Sell Ratings
  • 7 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
▼ -2 (-1.80%)

This chart shows the closing price for MTH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Meritage Homes Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MTH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MTH

Analyst Price Target is $116.25
▲ +6.57% Upside Potential
This price target is based on 10 analysts offering 12 month price targets for Meritage Homes in the last 3 months. The average price target is $116.25, with a high forecast of $135.00 and a low forecast of $100.00. The average price target represents a 6.57% upside from the last price of $109.08.

This chart shows the closing price for MTH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart
Inflation Skyrockets By 300% In 2021
Right now, we're seeing the highest inflation rates since 2008. The White House is printing trillions of dollars, devaluing your dollar, and raising prices for everyone.

Current Consensus is Hold

The current consensus among 10 investment analysts is to hold stock in Meritage Homes. This rating has held steady since October 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 0 sell ratings
  • 1 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
  • 1 strong buy ratings
  • 2 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 1 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 0 sell ratings
  • 1 strong buy ratings
  • 2 buy ratings
  • 7 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 4 buy ratings
  • 7 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 4 buy ratings
  • 7 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 7 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 7 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/4/2021Wolfe ResearchUpgradePeer Perform ➝ Outperform$130.00Medium
7/30/2021KeyCorpBoost Price TargetOverweight$120.00 ➝ $130.00Low
6/30/2021The Goldman Sachs GroupLower Price TargetNeutral$117.00 ➝ $110.00Low
4/21/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$100.00N/A
4/19/2021KeyCorpBoost Price TargetOverweight$100.00 ➝ $110.00Medium
4/15/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$100.00High
3/16/2021Wolfe ResearchInitiated CoveragePeer PerformLow
2/22/2021KeyCorpInitiated CoverageOverweight$100.00High
2/2/2021JPMorgan Chase & Co.Lower Price TargetNeutral$123.00 ➝ $116.00Low
1/29/2021Credit Suisse GroupLower Price TargetOutperform$134.00 ➝ $106.00Medium
1/29/2021BTIG ResearchDowngradeBuy ➝ NeutralHigh
1/29/2021Bank of AmericaDowngradeBuy ➝ Neutral$121.00 ➝ $103.00High
1/21/2021Janney Montgomery ScottInitiated CoverageNeutralHigh
10/23/2020Credit Suisse GroupBoost Price TargetOutperform$132.00 ➝ $134.00High
10/16/2020BTIG ResearchBoost Price TargetBuy$117.00 ➝ $135.00High
10/13/2020Zelman & AssociatesDowngradeBuy ➝ HoldHigh
10/8/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$114.00 ➝ $137.00High
9/22/2020Bank of AmericaBoost Price TargetBuy$125.00 ➝ $138.00High
9/21/2020Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$120.00Low
7/24/2020Credit Suisse GroupBoost Price TargetOutperform$96.00 ➝ $113.00Low
7/23/2020Evercore ISIUpgradeOutperformHigh
7/21/2020BTIG ResearchUpgradeNeutral ➝ Buy$109.00Medium
7/16/2020The Goldman Sachs GroupUpgradeSell ➝ Neutral$64.00 ➝ $80.00Medium
6/11/2020JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$88.00High
5/27/2020Credit Suisse GroupInitiated CoverageOutperform$81.00High
4/30/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$40.00 ➝ $55.00Low
4/29/2020CfraLower Price TargetStrong-Buy$87.00 ➝ $65.00High
3/18/2020JPMorgan Chase & Co.Lower Price TargetNeutral$76.00 ➝ $38.00High
1/28/2020Evercore ISIUpgradeIn-Line ➝ Outperform$67.00 ➝ $77.00High
12/6/2019The Goldman Sachs GroupInitiated CoverageSell$59.00High
11/21/2019Evercore ISIReiterated RatingHold$76.00High
10/24/2019Wells Fargo & CompanyBoost Price TargetMarket Perform$70.00 ➝ $82.00Low
9/18/2019Bank of AmericaBoost Price TargetBuy$79.00 ➝ $82.00Low
9/11/2019JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$54.50 ➝ $67.50High
7/25/2019CitigroupUpgradeNeutral ➝ Buy$55.00 ➝ $63.00High
4/12/2019Zelman & AssociatesUpgradeHold ➝ BuyMedium
3/7/2019JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$36.00High
3/5/2019WedbushLower Price TargetNeutral ➝ Neutral$41.00 ➝ $39.00High
2/1/2019JMP SecuritiesDowngradeOutperform ➝ Market Perform$45.08Low
2/1/2019CitigroupDowngradeBuy ➝ Neutral$45.00 ➝ $50.00Low
1/31/2019Keefe, Bruyette & WoodsReiterated RatingHold$47.00Low
1/10/2019WedbushDowngradeOutperform ➝ Neutral$41.00Low
1/4/2019CitigroupLower Price TargetBuy ➝ Buy$47.00 ➝ $45.00Low
10/26/2018WedbushBoost Price TargetOutperform$41.00 ➝ $54.00High
10/26/2018JMP SecuritiesSet Price TargetBuy$47.00Medium
10/25/2018Evercore ISIUpgradeIn-Line ➝ Outperform$47.00 ➝ $43.00High
10/22/2018Deutsche Bank AktiengesellschaftUpgradeHold ➝ BuyMedium
10/17/2018Credit Suisse GroupReiterated RatingOutperform ➝ Neutral$50.00 ➝ $36.00High
10/11/2018JMP SecuritiesReiterated RatingBuy$58.00 ➝ $48.00Medium
10/11/2018Bank of AmericaSet Price TargetBuy$51.00High
9/21/2018JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$55.00 ➝ $46.00Low
7/27/2018Wells Fargo & CompanyLower Price TargetMarket Perform ➝ Market Perform$57.00 ➝ $49.00Low
7/27/2018WedbushLower Price TargetOutperform ➝ Buy$55.00 ➝ $54.00Low
7/26/2018Credit Suisse GroupLower Price TargetOutperform ➝ Outperform$53.00 ➝ $50.00High
6/27/2018CitigroupReiterated RatingBuy$55.00Low
6/19/2018CitigroupInitiated CoverageBuy ➝ Buy$64.00 ➝ $55.00Low
5/14/2018Bank of AmericaUpgradeNeutral ➝ BuyLow
4/29/2018BTIG ResearchReiterated RatingHoldMedium
4/27/2018JMP SecuritiesBoost Price TargetMarket Outperform ➝ Market Outperform$57.00 ➝ $58.00Low
4/26/2018Credit Suisse GroupLower Price TargetOutperform ➝ Outperform$60.00 ➝ $53.00High
3/21/2018Keefe, Bruyette & WoodsReiterated RatingHold$50.00Medium
3/20/2018WedbushInitiated CoverageOutperform ➝ Outperform$55.00Low
3/7/2018JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$44.75 ➝ $58.00Low
2/14/2018Bank of AmericaUpgradeUnderperform ➝ Neutral$55.00Medium
2/2/2018Bank of AmericaBoost Price TargetUnderperform ➝ Underperform$51.00 ➝ $55.00Medium
2/2/2018JMP SecuritiesBoost Price TargetMarket Outperform ➝ Market Outperform$55.00 ➝ $57.00Medium
2/2/2018BarclaysUpgradeUnderweight ➝ Equal WeightMedium
1/22/2018Credit Suisse GroupUpgradeNeutral ➝ Outperform$52.00 ➝ $60.00Low
1/17/2018UBS GroupReiterated RatingNeutral ➝ Neutral$52.00 ➝ $57.00Low
1/8/2018CitigroupUpgradeNeutral ➝ Buy$51.00Low
10/30/2017CitigroupBoost Price TargetNeutral$46.00 ➝ $51.00N/A
10/25/2017UBS GroupInitiated CoverageNeutral$52.00N/A
8/2/2017BarclaysReiterated RatingUnderweight$36.00 ➝ $38.00Low
8/2/2017Deutsche Bank AktiengesellschaftBoost Price TargetHold$40.00 ➝ $42.00Low
7/13/2017BarclaysReiterated RatingUnderweightLow
6/28/2017Bank of AmericaReiterated RatingUnderperform$36.00 ➝ $38.00Medium
6/22/2017Credit Suisse GroupInitiated CoverageNeutral$40.00Low
4/27/2017Keefe, Bruyette & WoodsReiterated RatingHold$37.00High
4/3/2017JMP SecuritiesUpgradeMarket Perform ➝ Outperform$50.00Medium
3/7/2017BarclaysReiterated RatingUnderweight$36.00N/A
2/7/2017BTIG ResearchInitiated CoverageNeutralN/A
1/30/2017Evercore ISIDowngradeBuy ➝ Hold$37.00N/A
1/5/2017BarclaysInitiated CoverageUnderweight$36.00N/A
11/14/2016Evercore ISIInitiated CoverageBuyN/A
9/28/2016Wells Fargo & CompanyInitiated CoverageMarket PerformN/A
8/17/2016UBS GroupReiterated RatingSellN/A
(Data available from 8/5/2016 forward)
Meritage Homes logo
Meritage Homes Corporation designs and builds single-family homes in the United States. The company operates through two segments, Homebuilding and Financial Services. It acquires and develops land; and constructs, markets, and sells homes for first-time and first move-up buyers. The company also offers title insurance and closing/settlement services to its homebuyers. It builds and sells homes in Texas, Arizona, California, Colorado, Florida, North Carolina, South Carolina, Georgia, and Tennessee under the Meritage Homes brand name. Meritage Homes Corporation was founded in 1985 and is based in Scottsdale, Arizona.
Read More

Today's Range

Now: $109.08
Low: $108.29
High: $111.27

50 Day Range

MA: $97.61
Low: $88.30
High: $111.08

52 Week Range

Now: $109.08
Low: $78.00
High: $120.19


335,349 shs

Average Volume

353,060 shs

Market Capitalization

$4.11 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Meritage Homes?

The following sell-side analysts have issued stock ratings on Meritage Homes in the last year: Bank of America Co., BTIG Research, Credit Suisse Group AG, Janney Montgomery Scott, JPMorgan Chase & Co., KeyCorp, The Goldman Sachs Group, Inc., Wells Fargo & Company, Wolfe Research, Zacks Investment Research, and Zelman & Associates.
View the latest analyst ratings for MTH.

What is the current price target for Meritage Homes?

7 Wall Street analysts have set twelve-month price targets for Meritage Homes in the last year. Their average twelve-month price target is $114.29, suggesting a possible upside of 2.9%. BTIG Research has the highest price target set, predicting MTH will reach $135.00 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $100.00 for Meritage Homes in the next year.
View the latest price targets for MTH.

What is the current consensus analyst rating for Meritage Homes?

Meritage Homes currently has 7 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in MTH, but not buy more shares or sell existing shares.
View the latest ratings for MTH.

What other companies compete with Meritage Homes?

How do I contact Meritage Homes' investor relations team?

Meritage Homes' physical mailing address is 8800 EAST RAINTREE DRIVE SUITE 300, SCOTTSDALE AZ, 85260. The construction company's listed phone number is 480-515-8100 and its investor relations email address is [email protected] The official website for Meritage Homes is

Seattle Cannabis Blockbuster Set to Double Sales in Next 2 Years!
Thanks to a recent reorganization, acquisitions, and strategic partnerships, one Seattle cannabis blockbuster is poised for a massive expansion in the coming 24 months. With plans to double its annual sales in the next two years, this company’s shares could potentially skyrocket in value.